SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease
JACC: Asia · 2026-06 · 6 (6) · 839-847
DOI: 10.1016/j.jacasi.2026.03.034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Asia, 2026-06. Verfasst von Olivier Morel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hanoi Medical University, Hanoi, Vietnam; Department of Cardiology, University Hospital of Strasbourg, Strasbourg, France; Research Unit UR3074, Tran…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hanoi Medical University, Hanoi, Vietnam; Department of Cardiology, University Hospital of Strasbourg, Strasbourg, France; Research Unit UR3074, Translational Cardiovascular Medicine, University of Strasbourg, Strasbour…
- University of Cape-Town, South Africa, South African Medical Research Council.
- African Research Network, Dakar, Senegal; Paris Cardiovascular Research Center INSERM U97O, Paris, France.
- Rwanda Rheumatic Heart Disease Research Network, Kigali, Rwanda; Jefferson Einstein Medical Center, Philadelphia, Pennsylvania, USA; Team Heart, Boston, Massachusetts, USA.
- Rwanda Rheumatic Heart Disease Research Network, Kigali, Rwanda; Team Heart, Boston, Massachusetts, USA.
- Division of Cardiology, University Hospitals, Geneva, Switzerland.
Zitieren
APA
Morel, O., Mai, A. T., Zühlke, L., Jouven, X., Marchandot, B., Pressman, G., Patton-Bolman, C., Roffi, M., & Pibarot, P. (2026). SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease. JACC: Asia, 6(6), 839-847. https://doi.org/10.1016/j.jacasi.2026.03.034
Vancouver
Morel O, Mai AT, Zühlke L, Jouven X, Marchandot B, Pressman G, et al. SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease. JACC: Asia. 2026;6(6):839-847. doi:10.1016/j.jacasi.2026.03.034
BibTeX
@article{Morel2026,
author = {Morel, Olivier and Mai, Anh Trung and Zühlke, Liesl and Jouven, Xavier and Marchandot, Benjamin and Pressman, Gregg and Patton-Bolman, Ceeya and Roffi, Marco and Pibarot, Philippe},
title = {SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease},
journal = {JACC: Asia},
year = {2026},
volume = {6},
number = {6},
pages = {839--847},
doi = {10.1016/j.jacasi.2026.03.034}
}
EUVIMED